AVALO THERAPEUTICS, INC. Finite-Lived Intangible Assets, Accumulated Amortization
AVALO THERAPEUTICS, INC. (AVTX) had Finite-Lived Intangible Assets, Accumulated Amortization of $5.96 million as of 2022-12-31, per its 10-K filed 2023-03-29.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization · last filed 2023-03-29
- 2022-12-31: Finite-Lived Intangible Assets, Accumulated Amortization $5.96M.
- 2021-12-31: Finite-Lived Intangible Assets, Accumulated Amortization $5.92M.
- 2020-12-31: Finite-Lived Intangible Assets, Accumulated Amortization $4.52M; Finite-Lived Intangible Assets, Accumulated Amortization as first filed $4.52M.
- 2019-12-31: Finite-Lived Intangible Assets, Accumulated Amortization $2.78M.
| Period end | Finite-Lived Intangible Assets, Accumulated Amortization | Finite-Lived Intangible Assets, Accumulated Amortization as first filed |
|---|---|---|
| 2022-12-31 | $5.96M 10-K · filed 2023-03-29 | |
| 2021-12-31 | $5.92M 10-K · filed 2023-03-29 | |
| 2020-12-31 | $4.52M 10-K · filed 2022-03-02 | $4.52M 10-K · filed 2021-03-08 |
| 2019-12-31 | $2.78M 10-K · filed 2021-03-08 | |
| 2018-12-31 | $2.13M 10-K · filed 2020-03-11 | $4.94M 10-K · filed 2019-03-18 |
| 2017-12-31 | $403.52K 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |